Shydlovska TA, Bezeha,Volkova TV MI, Bezega BM
DISORDER OF SENSORY SYSTEMS – AUDITORY AND OLFACTORY ANALYSERS IN PATIENTS WHO HAVE HAD THE COVID-19
Shydlovska Tetiana A
State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine”; Kyiv, Ukraine.
Head of the laboratory of voice and hearing
Doctor of Medical Sciences, Professor
E-mail: lorprof3@ukr.net
Orchid ID: https://orcid.org/0000-0002-7894-359X
Bezega Mychailo I
Poltava State Medical University
Department of Otorhinolaryngology with Ophthalmology
Candidate of Medical Sciences
Email: bezega_lor@ukr.net, lorbezega@gmail.com
ORCID ID: https://orcid.org/0000-0002-1250-1190
Volkova Tetyana V
State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine”; Kyiv, Ukraine.
Laboratory for Occupational Voice and Hearing
Junior Researcher
E-mail: amtc@kndio.kiev.ua
Orchid ID: https://orcid.org/0000-0002-3830-1533
Bezeha Bohdan M
Communal enterprise «M.V. Sklifosovsky Poltava Regional Clinical Hospital Poltava Regional Council»
ENT department
Otolaryngologist
Email: bogdanbezegalor@gmail.com
ORCID ID: https://orcid.org/0000-0003-0517-9989
Abstract
Many disorders with various clinical manifestations are observed in COVID-19 coronavirus infection, including dam-age to the cardiovascular, central nervous systems and other organs and systems of the human body. The functions of sensory systems and higher nervous activity may also be affected by COVID-19. However, the issue is not sufficiently understood at the moment.
The purpose of the study is to assess the state of the sensory systems – auditory, taste and olfactory analysers in people with COVID-19 based on the analysis of complaints and anamnesis data, taking into account the severity of its course.
Materials and methods: We analysed survey data, anamnesis and complaints of 122 patients with COVID-19. All sub-jects were divided into two groups according to the clinical course of the disease: group 1 included patients with mild COVID-19 – 63 patients, and group 2 – 59 patients with moderate infection.
Results and discussion: In the more severe COVID-19, complaints of hearing, smell, voice, and vestibular function disorders are more frequent. At the same time, the manifestations of such sensory system disorders were more pronounced in patients in group 2. Patients in group 1 complained of hearing impairment in 41.3%, voice impairment in 26.9%, vestibular function in 33.3%, and general complaints from the central nervous system in 77.7%. In group 2, the following complaints were observed in a higher percentage of cases: hearing impairment 57.6%, voice impairment 33.9%, vestibular function 45.7%, and general CNS complaints 91.5%.
In general, 49.2% of the surveyed complained of hearing impairment in the form of decreased hearing sensitivity, changes in speech intelligibility, and tinnitus. After COVID-19 infection, even in mild form, 36.5% of patients often complained of hearing loss. The number of moderate cases was 42.4%. Patients also noted a deterioration in speech intelligibility (Group 1 – 14.3%, Group 2 – 16.9%) and tinnitus (Group 1 – 38.1%, Group 2 – 55.9%. In 36.9% of the examined patients, hearing impairment was present before COVID-19, and the disease led to the progression of HNP. In group 1, 33.3% of such cases were in group 2, and 40.7% in group 3.
The number of patients complaining of olfactory impairment in the first group was 65.1%, and in the second group – 69.4%. In all patients with olfactory disorders, such disorders occurred during the disease and, in most cases, disappeared after recovery, but in 4.8% of cases in group 1 and 16.9% in group 2, persistent olfactory disorders occurred that persisted for a long time, mainly in the form of anosmia and hyposmia.
When analysing the duration of some complaints, significant differences were found between the groups both during illness and long after recovery. The presence of long-term sensory systems and CNS disorders after COVID-19 is of the most significant interest. In group 2, persistent olfactory disorders in the form of anosmia (16.9%) and hyposomia (6.8%), hearing impairment (27.1%), subjective tinnitus (33,9%), ear congestion (16.9%), headache (45.7%), memory and attention disorders (44.1%), sleep disorders (45.7%), fatigue, general weakness (69.4%).
Thus, patients with COVID-19 often complain of impaired hearing, smell, taste, voice, vestibular function, and general CNS complaints. Moreover, there are often persistent disorders of sensory functions that persist for a long time after the dis-ease.
Conclusions:
Key words: COVID-19, auditory disorders, olfactory disorders.